Loading...
Loading...
Columbia Laboratories, Inc.
CBRX received notice on August
23, 2012, from the Nasdaq Stock Market that the Company has regained
compliance with the Nasdaq Stock Market minimum bid price requirement as
set forth in Listing Rule 5550(a)(2). The notice stated that the closing
bid price of the Company's common stock has been at $1.00 per share or
greater for the previous ten consecutive business days.
About Columbia Laboratories
Columbia Laboratories, Inc. is a publicly traded specialty
pharmaceutical company with a successful history of developing
proprietary, vaginally administered products for women's health
indications. For more information, please visit www.columbialabs.com.
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in